共 45 条
[1]
Fisher R(2014)ILAE official report: a practical clinical definition of epilepsy Epilepsia 55 475-482
[2]
Amudhan S(2015)Epilepsy in India I: epidemiology and public health Ann Indian Acad Neurol 18 263-277
[3]
Gururaj G(2012)Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid Pharmacogenomics. 13 1055-1071
[4]
Satishchandra P(1997)Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyl transferase: pharmacological implications Pharmacogenetics. 7 485-495
[5]
Chatzistefanidis D(2003)Combined polymorphisms in UDP-glucuronosyl transferases 1A1 and 1A6: implications for patients with Gilbert's syndrome J Hepatol 38 3-8
[6]
Georgiou I(2014)Influence of uridine diphosphate glucuronosyl transferase 2B7-161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients Ther Drug Monit 36 406-409
[7]
Kyritsis AP(2013)The effect of uridine disphosphate glucuronosyltransferase (UGT) 1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach Mol Diagn Ther 17 319-326
[8]
Markoula S(2012)Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients Eur J Clin Pharmacol 68 1395-1401
[9]
Ciotti M(2012)Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy Drug Metab Pharmacokinet 27 536-542
[10]
Marrone A(1999)UDP-glucuronosyl transferase (UGT1A1 * 28 and UGT1A6 * 2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations Pharmacogenet. 9 341-349